Results
Dr. Lal PathLabs Q2 FY27 Net Profit Up 27.5%
Dr. Lal PathLabs reported Q2 FY27 revenue of Rs. 874 crore, a 19.6% YoY growth, with patient volume increasing 9%.
EBITDA grew 25.1% to Rs. 280 crore with a margin of 32.1%, while PAT increased 27.5%
